169 related articles for article (PubMed ID: 29459686)
1. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
Yan C; Li J; Feng S; Li Y; Tan L
Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
[TBL] [Abstract][Full Text] [Related]
2. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W
Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression.
Zhu X; Wu YB; Zhou J; Kang DM
Biochem Biophys Res Commun; 2016 Jan; 469(2):319-25. PubMed ID: 26603935
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
8. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of MicroRNA-592 in obesity contributes to hyperglycemia and insulin resistance.
Song Y; Wu L; Li M; Xiong X; Fang Z; Zhou J; Yan G; Chen X; Yang J; Li Y
EBioMedicine; 2019 Apr; 42():494-503. PubMed ID: 30948354
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 is downregulated in obese mice subjected to short-term strength training.
Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
[TBL] [Abstract][Full Text] [Related]
13. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
16. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
[TBL] [Abstract][Full Text] [Related]
17. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
18. N
Zhang J; Chen Y; Liu C; Li L; Li P
J Diabetes Res; 2020; 2020():1080152. PubMed ID: 32280711
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin inhibits hepatic gluconeogenesis in obese mice.
Barros CC; Haro A; Russo FJ; Schadock I; Almeida SS; Reis FC; Moraes MR; Haidar A; Hirata AE; Mori M; Bacurau RF; Würtele M; Bader M; Pesquero JB; Araujo RC
Lab Invest; 2012 Oct; 92(10):1419-27. PubMed ID: 22868909
[TBL] [Abstract][Full Text] [Related]
20. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
